Acute leukemias after treatment with radioiodine for thyroid cancer.
نویسندگان
چکیده
Leukemia is an uncommon complication of exposure to radioiodine (131I), used in treatment of thyroid cancer, because low doses are now used. We report two cases of acute myelogenous leukemia developed after the treatment of a thyroid carcinoma with a small dose of 131I.
منابع مشابه
A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancer
Radioiodine is regularly used in the treatment of thyroid cancer to eliminate residual malignant tissue after thyroidectomy and to treat metastasis. Because of the low dose of radioiodine used to treat thyroid cancer patients, leukemia is an uncommon complication of exposure to radioiodine. Here, we present a patient who developed therapy-related acute myeloid leukemia with inv(16)(p13.1q22);CB...
متن کاملPredictors of success of the ablative/therapeutic radioiodine (131I) in differentiated thyroid cancer
Introduction:Differentiatedthyroid carcinoma (DTC) constitute approximately 90% of all thyroid tumors with an overall excellent prognosis. However, there is a small group of patients with a more aggressive form of disease, usually associated with certain poor prognostic factors. Using our large database of patients with DTC, the current study aims at identifying some of these f...
متن کاملRadioiodine treatment effects on lacrimal glands function in patients with thyroid cancer [Persian]
Introduction: There is a limited number of case reports published in the past decade confirming the radio-iodine presence in the tear. These observations as well as reported cases of salivary and lacrimal gland dysfunction after radioiodine therapy stimulated investigators to clarify whether lacrimal gland function can be affected post-radioiodine therapy. Hence we ...
متن کاملEffects of early liothyronine consumption after radioiodine therapy on accumulated dose and exposure rate in patients with thyroid carcinoma
Introduction: Patients administered with a therapeutic dose of 131I for thyroid cancer treatment are potential sources of unacceptably high radiation exposure to other individuals, particularly the patient's immediate family members. The aim of this study is to investigate effects of early liothyronine consumption after radio-iodine therapy on accumulated dose and e...
متن کاملAcute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases.
Introduction Radioiodine (I) has been used in the treatment of thyroid cancer in order to eliminate residual thyroid tissue after thyroidectomy and to treat metastatic disease. Leukemia is one of the most prominent late effects of exposure to ionising radiation, but is an uncommon complication of exposure to I. We report here on two patients who were admitted to our clinic 12 and 17 years after...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Haematologica
دوره 83 8 شماره
صفحات -
تاریخ انتشار 1998